Some studies demonstrate the effectiveness of using drugs such as sacubitril/valsartan and SGLT2 inhibitors for the treatment of heart failure (34); however, this drug has only been proved to be applicable to the treatment of heart failure in adults, and no study has proved that this drug can be applied to children. Here, SLC5A2 is linked to heart failure.